Clinical Responses to Undiluted and Diluted Smallpox Vaccine
- 25 April 2002
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 346 (17), 1265-1274
- https://doi.org/10.1056/nejmoa020534
Abstract
To evaluate the potential to increase the supply of smallpox vaccine (vaccinia virus), we compared the response to vaccination with 108.1, 107.2, and 107.0 plaque-forming units (pfu) of vaccinia virus per milliliter.Keywords
This publication has 11 references indexed in Scilit:
- Dose-Related Effects of Smallpox VaccineThe New England Journal of Medicine, 2002
- Vaccination of Vaccinia-Naive Adults with Human Immunodeficiency Virus Type 1 gp160 Recombinant Vaccinia Virus in a Blinded, Controlled, Randomized Clinical TrialThe Journal of Infectious Diseases, 1992
- The effect of the virus-serum incubation period upon vaccinia virus serum neutralization titersJournal of Biological Standardization, 1987
- Disseminated Vaccinia in a Military Recruit with Human Immunodeficiency Virus (HIV) DiseaseThe New England Journal of Medicine, 1987
- Primary Subcutaneous VaccinationThe Journal of Infectious Diseases, 1977
- Primary Percutaneous VaccinationThe Journal of Infectious Diseases, 1977
- Vaccinia necrosum and its relationship to impaired immunologic responsivenessAmerican Journal Of Medicine, 1972
- Complications of Smallpox Vaccination in Alabama, 1968Southern Medical Journal, 1972
- Complications of Smallpox Vaccination, 1968: Results of Ten Statewide SurveysThe Journal of Infectious Diseases, 1970
- Progressive Vaccinia with Normal AntibodiesAnnals of Internal Medicine, 1964